Maternal hypothyroidism may be associated with CHD in offspring

Cardiology in the Young

Volumn 25, Issue 7, 2014, Pages 1247-1253

  Grattan, Michael J ^a   Thomas, Daina S ^b   Hornberger, Lisa K ^a   Hamilton, Robert M ^c   Midodzi, William K ^d   Vohra, Sunita ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

CHD; maternal hypothyroidism; nausea and vomiting in pregnancy

Indexed keywords

ADOLESCENT; ADULT; CANADA; CASE CONTROL STUDY; CHILD; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HUMAN; HYPOTHYROIDISM; INFANT; MALE; MOTHER; NAUSEA; NEWBORN; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; VOMITING;

ADOLESCENT; ADULT; CANADA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MOTHERS; NAUSEA; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; VOMITING;

EID: 84941076121     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951114001887     Document Type: Article

References (38)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900.
2. Glinoer D. Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. Horm Res 2001; 55: 109-114.
3. Lisowski LA, Verheijen PM, Copel JA, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz 2010; 35: 19-26.
4. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1081-1125.
5. Spence D, Hornberger L, Hamilton R, Silverman ED. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies. J Rheumatol 2006; 33: 167-170.
6. Browne ML, Rasmussen SA, Hoyt AT, et al. Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2009; 85: 621-628.
7. Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 2013; 128: 583-589.
8. Robert E, Vollset SE, Botto L, et al. Malformation surveillance and maternal drug exposure: the MADRE project. Int J Risk Saf Med 1994; 6: 75-118.
9. Wikner BN, Sparre LS, Stiller CO, Kallen B, Asker C. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol Scand 2008; 87: 617-627.
10. Khoury MJ, Becerra JE, d'Almada PJ. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol 1989; 3: 402-420.
11. Boneva RS, Moore CA, Botto L, Wong LY, Erickson JD. Nausea during pregnancy and congenital heart defects: a population-based case-control study. Am J Epidemiol 1999; 149: 717-725.
12. Goodwin TM, Hershman JM. Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol 1997; 40: 32-44.
13. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroid-ism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992; 167: 648-652.
14. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroid-ism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992; 75: 1333-1337.
15. Leylek OA, Cetin A, Toyaksi M, Erselcan T. Hyperthyroidism in hyperemesis gravidarum. Int J Gynaecol Obstet 1996; 55: 33-37.
16. Nader S, Mastrobattista J. Recurrent hyperthyroidism in consecutive pregnancies characterized by hyperemesis. Thyroid 1996; 6: 465-466.
17. Vohra S, Koren G. Hypothetical framework for a relationship between maternal thyroid function, nausea and vomiting of pregnancy, and congenital heart disease. Med Hypotheses 2001; 56: 392-394.
18. Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 1996; 20: 465-472.
19. Berkow R, Merck Research Laboratories. The Merck Manual of Medical Information: Home Edition. Merck Research Laboratories, Whitehouse Station, New Jersey, 1997.
20. Bloch W, Fleischmann BK, Lorke DE, et al. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 1999; 43: 675-684.
21. Sinha RA, Pathak A, Mohan V, Bandyopadhyay S, Rastogi L, Godbole MM. Maternal thyroid hormone: a strong repressor of neuronal nitric oxide synthase in rat embryonic neocortex. Endocrinology 2008; 149: 4396-4401.
22. Oceandy D, Cartwright EJ, Emerson M, et al. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation 2007; 115: 483-492.
23. Lynch JM, Chilibeck K, Qui Y, Michalak M. Assembling pieces of the cardiac puzzle; calreticulin and calcium-dependent pathways in cardiac development, health, and disease. Trends Cardiovasc Med 2006; 16: 65-69.
24. Prins D, Michalak M. Endoplasmic reticulum proteins in cardiac development and dysfunction. Can J Physiol Pharmacol 2009; 87: 419-425.
25. Ridings JE, Palmer AK, Davidson EJ, Baldwin JA. Prenatal toxicity studies in rats and rabbits with the calcium channel blocker diproteverine. Reprod Toxicol 1996; 10: 43-49.
26. Scott WJ Jr., Resnick E, Hummler H, Clozel JP, Burgin H. Cardiovascular alterations in rat fetuses exposed to calcium channel blockers. Reprod Toxicol 1997; 11: 207-214.
27. Reed TD, Babu GJ, Ji Y, et al. The expression of SR calcium transport ATPase and the Na(+)/Ca(2 +)exchanger are antithetically regulated during mouse cardiac development and in hypo/hyperthyroidism. J Mol Cell Cardiol 2000; 32: 453-464.
28. Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 2003; 102: 232-241.
29. Maran RR. Thyroid hormones: their role in testicular steroidogenesis. Arch Androl 2003; 49: 375-388.
30. Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET. Activin betaB expression in rat experimental goiter and human thyroid tumors. Thyroid 2003; 13: 239-247.
31. Kosaki R, Gebbia M, Kosaki K, et al. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet 1999; 82: 70-76.
32. Ticho BS, Goldstein AM, Van Praagh R. Extracardiac anomalies in the heterotaxy syndromes with focus on anomalies of midline-associated structures. Am J Cardiol 2000; 85: 729-734.
33. Kokan-Moore NP, Bolender DL, Lough J. Secretion of inhibin beta A by endoderm cultured from early embryonic chicken. Dev Biol 1991; 146: 242-245.
34. Smedts HP, van Uitert EM, Valkenburg O, et al. A derangement of the maternal lipid profile is associated with an elevated risk of congenital heart disease in the offspring. Nutr Metab Cardiovasc Dis 2012; 22: 477-485.
35. Haddad F, Jiang W, Bodell PW, Qin AX, Baldwin KM. Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications. Am J Physiol Heart Circ Physiol 2010; 299: H1968-H1980.
36. Pandya K, Kohro T, Mimura I, et al. Distribution of histone3 lysine 4 trimethylation at T3-responsive loci in the heart during reversible changes in gene expression. Gene Expression 2012; 15: 183-198.
37. Bryant HE, Visser N, Love EJ. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and postnatal women. Am J Pub Health 1989; 79: 78-80.
38. Roodpeyma S, Kamali Z, Afshar F, Naraghi S. Risk factors in congenital heart disease. Clin Pediatr 2002; 41: 653-658.